Citations

Clear

9383 citation(s) found for "Thomas, PS".

Covered Self-Expandable Metallic Stents versus Multiple Plastic Stents for Benign Biliary Strictures: A Systematic Review, Meta-Analysis, and Trial Sequential Analysis
Nayfeh, Tarek , Majzoub, Abdul Monaem, Malik, Alexander, Osman, Karim, Hassett, Leslie, Mousa, Jehan , Noureddin, Nabil , Beran, Azizullah Ahmadallah, Kamal, Faisal, Saleem, Nasir, Nayfeh, Tarek , Majzoub, Abdul M., Aboursheid, Tarek , Malik, Alexander, Osman, Karim T. , Hassett, Leslie C. , Malandris, Konstantinos , Beran, Azizullah , Kamal, Faisal, Saleem, Nasir

Mayo Clinic

Avicenna Journal of Medicine | March 24, 2026 | Volume: 16 | Issue: 01 | Pages: 016-026

10.1055/s-0046-1818623 | PMID 42344705 Get It

Abstract We aim to compare the benefits, harms, and costs of multiple plastic stents (MPS) versus covered self-expandable metallic stents (CSEMS) in the treatment of benign biliary strictures (BBS). A comprehensive database search through June 6, 2024 identified randomized controlled trials (RCT) involving adult patients with BBS comparing MPS to CSEMS in terms of stricture resolution, recurrence, technical success, number of required procedures and stents, treatment duration, all-cause mortality, adverse events, and stent migration. We utilized the Cochrane Risk of Bias (RoB) tool2 for study quality assessment. Meta-analysis following the random effects model was performed. After screening 365 references, we included 7 RCTs (high RoB) involving 594 patients. Most reported stricture etiology is chronic pancreatitis (52.4%), followed by orthotopic liver transplant (40.5%). Compared with MPS, CSEMS achieved similar efficacy and safety. However, CSEMS required fewer procedures (mean difference [MD]: −1.84 [−2.56 to −1.11]; I2 = 76%) and stents (MD: −6.04 [−9.55 to −2.52]; I2 = 93%), amounting for shorter duration of treatment (MD: −119.02 days [−137.41 to −100.62]; I2 = 96%) and savings in costs between 41 and 57% with absolute savings of 4,019$ to 9,192$ favoring CSEMS. All outcomes had a low to very low certainty of evidence (CoE), except for technical success and stricture resolution (moderate CoE). Our analysis suggests that CSEMSs are comparable to MPSs in terms of efficacy and safety. However, it shows that CSEMSs are more cost-effective. Sample size calculations from our analyses can guide the design of future studies to validate the safety profiles and determine the feasibility of the two modalities.
Brain-Only Versus GI-Only Synucleinopathy: A Comprehensive Autopsy Study With Both IHC and SAA
Orru, Christina D., Beach, Thomas G., Adler, Charles H., Shill, Holly A., Driver-Dunckley, Erika, Mehta, Shyamal H. , Atri, Alireza, Lorenzini, Ileana , Qiji, Sanaria H., Intorcia, Anthony J., Hughson, Andrew G., Groveman, Bradley R. , King, Samantha, Parveen, Sabiha , Caughey, Byron, Serrano, Geidy E , Orru, Christina Doriana , Beach, Thomas G. , Adler, Charles H. , Shill, Holly A. , Driver‐Dunckley, Erika , Atri, Alireza , Hughson, Andrew G. , Alam, Parvez , Vascellari, Sarah , Caughey, Byron W. , Serrano, Geidy E.

Mayo Clinic

No container title available | March 24, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.64898/2026.03.18.26348355 | PMID 41929295 Get It

ABSTRACT Braak and others have proposed that Lewy body pathology (LBP) in Parkinson’s disease (PD) may arise not only in the brain but alternatively from an initial site in the gastrointestinal (GI) tract with subsequent passage to the central nervous system CNS through the vagus nerve or other routes. We tested this hypothesis by using both immunohistochemistry (IHC) and RT QuIC a form of alpha synuclein seed amplification assay (SAA) to detect alpha synuclein LBP in samples from selected brain regions and 10 GI tract sites taken from autopsies of 50 PD subjects and 128 elderly subjects without parkinsonism or dementia including 34 with IHC identified CNS incidental Lewy body disease (ILBD) and 94 with no Lewy body IHC pathology detected (NLB). A positive SAA or IHC result was restricted to the GI tract in only 2 subjects while LBP by either SAA or IHC was restricted to the brain in 11 subjects. To fairly compare GI-only with brain-only synucleinopathy, however, we would have to do SAA on brain samples from all ILBD and NLB cases in at least 4 critical brain regions: olfactory bulb, medulla, pons, and amygdala. Further SAA of brain regions is estimated, based on the proportional results to date, to potentially identify 21 additional brain-only LBP subjects, for a total of 32, if it were done on all of the NLB subjects. From this brain-only LBP is estimated to be 16 times more common than GI-only LBP. To assess the clinical impact of SAA-positive GI sites we found that the number of positive sites per subject is significantly correlated with UPDRS motor score and SCOPA-AUT GI related scores including those for salivation, straining, constipation, and bowel movement.
Clinical Criteria for the Definition of Refractory Septic Shock: A Joint Delphi Consensus from the Society of Critical Care Medicine (SCCM) and European Society of Intensive Care Medicine (ESICM)
Myatra, Sheila Nainan , Dugar, Siddharth , Russell, Lene , Delamarre, Louis , Sharif, Sameer , Chew, Michelle S. , Gong, Michelle N. , Hernández, Glenn , Martín‐Loeches, Ignacio , Dünser, Martin W., Einav, Sharon , Hamzaoui, Olfa, Frazee, Erin N. , Busse, Laurence W. , Deutschman, Clifford S. , Holder, Andre L. , Nazer, Lama , Nunnally, Mark , Rincon, Teresa , Seymour, Christopher W. , Besen, Bruno Adler Maccagnan Pinheiro , Finfer, Simon , Machado, Flávia Ribeiro , Mer, Mervyn , Young, Paul J. , Khanna, Ashish , Dugar, Siddharth , Wieruszewski, Patrick M , Russell, Lene , Evans, Laura , Delamarre, Louis , Sharif, Sameer , Chew, Michelle S , Gong, Michelle Ng , Hernández, Glenn , Schorr, Christa , Lakbar, Ines , Smith, Susan E , Martin-Loeches, Ignacio , Annane, Djillali , Balik, Martin , Cecconi, Maurizio , De Backer, Daniel , Donadello, Katia , Einav, Sharon , Ferrer, Ricard , Juffermans, Nicole , Hamzaoui, Olfa , Landoni, Giovanni , Levy, Bruno , McKenzie, Cathrine , Monnet, Xavier , Ostermann, Marlies , Spies, Claudia D , Singer, Mervyn , Theodorakopulou, Maria , Topeli, Arzu , Frazee, Erin N , Bauer, Seth R , Busse, Laurence W , Coopersmith, Craig M , Deutschman, Clifford , Holder, Andre L , Kamaleswaran, Rishikesan , Legrand, Matthieu , Martin, Greg S , Maves, Ryan C , Nazer, Lama , Nunnally, Mark E , Prescott, Hallie C , Rincon, Teresa , Sacha, Gretchen , Seymour, Chris W , Arabi, Yaseen M , Besen, Bruno Amp , Cavalcanti, Alexandre Biasi , Deane, Adam M , Finfer, Simon , Hammond, Naomi , Ibarra-Estrada, Miguel , Kattan, Eduardo , Kotani, Yuki , Machado, Flavia R , Ospina-Tascón, Gustavo A , Mer, Mervyn , Young, Paul J , Rochwerg, Bram , Khanna, Ashish K , Léone, Marc , Wieruszewski, Patrick M. , Smith, Susan , Backer, Daniel De , Dünser, Martin W. , Lévy, Bruno , McKenzie, Cathrine , Ostermann, Marlies , Spies, Claudia , Kamaleswaran, Rishikesan , Legrand, Matthieu , Martin, Greg S. , Maves, Ryan C. , Prescott, Hallie C. , Arabi, Yaseen M. , Deane, Adam M. , Hammond, Naomi

Mayo Clinic

Critical Care Medicine | March 24, 2026 | Volume: 54 | Issue: 5 | Pages: 1073-1091

10.1097/ccm.0000000000007124 | PMID 41873857 Get It

OBJECTIVE: A definition of refractory septic shock is necessary to guide diagnosis, management, prognostication, research, and future guidelines for this most severe form of the disease. We sought to achieve consensus on clinical criteria that would be used to define refractory septic shock. DESIGN: Review of literature, expert panel position statements, and Delphi rounds with an international expert group. SETTING: Consensus was defined as having at least 75% of panellists in agreement or disagreement on the three highest or lowest levels of a 7-point Likert scale or based on responses to single- or multiple-choice questions, respectively. SUBJECTS: A panel of multinational, multiprofessional and multidisciplinary critical care experts assembled by the Society of Critical Care Medicine and the European Society of Intensive Care Medicine (57 invitations and 56 participants). MEASUREMENTS AND MAIN RESULTS: A five-round Delphi process was conducted for consensus and stability. The steering committee proposed 34 statements, and five of them were rejected by panel experts after round 2. Among 29 statements selected from eight domains, consensus was reached for 13. The panel agreed on the need for a comprehensive consensus set of clinical criteria for refractory septic shock. Markers of organ dysfunction (75%, 2 rounds), tissue perfusion (91.1%, 2 rounds) including lactate (94.6%, 2 rounds) and capillary refill time (76.8%, 2 rounds), assessment of fluid-responsiveness after initial resuscitation (92.9%, 5 rounds), and use of vasoactive drugs at norepinephrine equivalents greater than 0.5 µg/kg/min (75.0%, 3 rounds), were selected as clinical criteria of refractory septic shock. The use of critical care ultrasound (CCUS) (92.9%, 3 rounds) was the single diagnostic modality that reached a consensus-based agreement. CONCLUSIONS: A consensus for 13 criteria to frame the definition of refractory septic shock was reached. Refractory septic shock is characterised by persistently elevated lactate concentrations and or prolonged capillary refill time in patients with septic shock who are fluid unresponsive, require a norepinephrine base equivalent dose greater than 0.5 micrograms per kilogram per minute, and undergo CCUS assessment when mixed shock is suspected.
777: EFFECT OF STEROIDS ON CYSTATIN C AND ESTIMATED GLOMERULAR FILTRATION RATE IN HOSPITALIZED PATIENTS
Williams, Victoria, Gerlach, Anthony, Cole, Kristin, Barreto, Jasón, Hernandez, Brandy, Kashani, Kianoush, Rule, Andrew, Wieruszewski, Patrick, Barreto, Erin, Gerlach, Anthony Thomas , Rule, Andrew D. , Wieruszewski, Patrick M. , Frazee, Erin N.

Mayo Clinic

Critical Care Medicine | March 24, 2026 | Volume: 54 | Issue: 3S | Pages: No page available

10.1097/01.ccm.0001185104.35935.bf Get It

Circulating levels of insulin‐like growth factor I ( IGF ‐I) and risk of multiple myeloma: An observational and Mendelian randomisation study
Benavente, Yolanda, Hermosa, Sara, Clay‐Gilmour, Alyssa, Brown, Elizabeth , Hofmann, Jonathan N., Rothman, Nathaniel, Lan, Qing, Berndt, Sonja I., Albanes, Demetrius, Purdue, Mark, Chanock, Stephen J., Norman, Aaron, Kumar, Shaji K., Vachon, C M, Novak, Anne J. , Ghesquieres, Herve, Bracci, Paige M., Holly, Elizabeth, Griffin, Rosalie G., Vermeulen, Roel , Hjalgrim, Henrik, Smedby, Karin Ekström, Cheah, Simon , Monnereau, Alain, Arslan, Alan, Zhang, Yawei, Camp, Nicola J., Sborov, Douglas W., Ziv, Elad , Joseph, Vijai, Teras, Lauren R., Patel, Alpa V. , Vajdic, Claire M., Cocco, Pierluigi, Alemany, Laia, McKay, James, Casabonne, Delphine , Monnereau, Alain , Brown, Elizabeth E , Machiela, Mitchell J , Slager, Susan L , Cerhan, James R , Rajkumar, S Vincent , Novak, Anne J , Habermann, Thomas , Salles, Gilles A , Hildebrandt, Michelle A T , Jayasekara, Harindra , Cheah, Simon , Kane, Eleanor , Guilloteau, Adrien , Casabonne, Delphine , Ziv, Elad , Benavente, Yolanda , Papadimitriou, Nikos , Clay‐Gilmour, Alyssa , Hofmann, Jonathan N. , Rothman, Nathaniel , Lan, Qing , Berndt, Sonja I. , Albanes, Demetrius , Machiela, Mitchell J. , Chanock, Stephen Jacob , Bhatti, Parveen , Cozen, Wendy , Slager, Susan L. , Cerhan, James R. , Rajkumar, S. Vincent , Habermann, Thomas M. , Link, Brian K. , Salles, Gilles , Ghesquières, Hervé , Bracci, Paige M. , Waller, Rosalie G. , Hildebrandt, Michelle A.T. , Kolijn, Pieter Martijn , Hjalgrim, Henrik , Jayasekara, Harindra , Chen, Yu , Camp, Nicola J. , Sborov, Douglas W. , Osman, Afaf E.G. , Vivo, Immaculata De , Teras, Lauren R. , Kane, Eleanor , Vajdic, Claire M. , Alemany, Laia, Sáinz, Juan , McKay, James, Birmann, Brenda M.

Mayo Clinic

British Journal of Haematology | March 24, 2026 | Volume: 208 | Issue: 6 | Pages: 1942-1953

10.1111/bjh.70444 | PMID 41873017 Get It

Summary Evidence for an association between insulin‐like growth factors (IGF) and multiple myeloma (MM) is inconsistent. We examined total IGF‐I concentrations and risk of MM by combining baseline serological data among UK Biobank participants ( n = 444 187; 732 incident MM) with a two‐sample Mendelian randomisation (MR) analysis using identified genetic variants associated with circulating total IGF‐I and IGF‐binding protein 3 (IGFBP‐3) in the InterLymph consortium (2434 MM and their 2567 controls). Finally, additional lymphoid neoplasm (LN) subtypes were included for comparison with the main hypothesis. Circulating IGF‐I level was positively associated with MM risk Hazard ratio‐HR‐per one standard deviation‐SD‐increase (HR 1‐SD = 1.11, 95% confidence interval [CI]: 1.01–1.22; p ‐value = 0.03), especially closer to diagnosis. Genetically inferred IGF‐I levels were associated with increased MM risk (odds ratio [OR] = 1.27, 95% CI: 1.05–1.54) but not with any other LNs. Genetically inferred IGFBP‐3 levels showed no associations with any LN evaluated. Corroborating previous findings, in a secondary analysis, IGF‐I levels were associated with the risk of chronic lymphocytic leukaemia/small lymphocytic lymphoma (CLL/SLL) in males with higher body mass index (HR 1‐SD in obese male = 1.36, 95% CI: 1.14–1.61). Our serological and MR analyses suggest a contributing role of IGF‐I in the susceptibility of MM; the CLL/SLL findings warrant further investigation considering sex‐specific adiposity.
Pediatric Cochlear Implantation for Single-Sided Deafness After Temporal Bone Fracture
Mendenhall, Taylor , Babajanian, Eric E. , Anderson, Cody M. , Pitt, Cache, Tooker, Evan L., Carlson, Matthew L., Patel, Neil S., Espahbodi, Mana , Carlson, Matthew L. , Patel, Neil S. , Gurgel, Richard Klaus

Mayo Clinic

Otology & Neurotology | March 24, 2026 | Volume: 47 | Issue: 5 | Pages: 684-690

10.1097/mao.0000000000004881 | PMID 41872113 Get It

Objective: To examine the benefit of cochlear implantation (CI) in pediatric patients with a history of temporal bone fracture resulting in single-sided deafness (SSD). Study design: Retrospective chart review. Setting: Two tertiary academic centers. Patients: Pediatric patients less than 18 years of age with SSD secondary to temporal bone fracture who underwent CI from 2012 to 2022. Intervention(s): CI. Main outcome measure(s): Postoperative audiometric testing. Results: Seven subjects were identified (median age: 10 years (y); Q1 to Q3: 5 to 16 y). Median time from temporal bone trauma to CI was 7 months (mo) (Q1 to Q3: 3 to 7 mo) and 85% had otic capsule involvement. Subjects were followed for a median length of 12 months (Q1 to Q3: 6 to 24 mo) after CI. All patients achieved full electrode insertion, though 2 required scala vestibuli insertion due to ossification of the scala tympani (one of whom had a history of meningitis after temporal bone fracture). Postoperative audiometric testing revealed variable speech perception outcomes with 4 of 7 obtaining open or closed set speech perception and 3 of 7 obtaining only sound awareness. No postoperative complications occurred. Conclusions: CI is a feasible intervention for SSD following pediatric temporal bone fractures, but outcomes are variable. Early evaluation and timely CI, ideally within 6 months of temporal bone fracture, may optimize outcomes. Cochlear ossification, either as a result of otic capsule fracture or subsequent meningitis, may lead to suboptimal outcomes.
Abstract PR009: Telomere length heterogeneity shapes structural and amplification landscapes in IDH-mutant astrocytoma
Ranallo-Benavidez, T. Rhyker, Keskus, Ayse, Eckel-Passow, J. E., Jenkins, Robert B., Jehangir, Maryam , Drucker, Kristen , Ranallo-Benavidez, T Rhyker , Kollmeyer, Thomas M. , Lachance, Daniel Honore , Eckel‐Passow, Jeanette E. , Shoshani, Ofer , Kolmogorov, Mikhail , Jenkins, Robert B. , Barthel, Floris P

Mayo Clinic

Cancer Research | March 23, 2026 | Volume: 86 | Issue: 6_Supplement | Pages: PR009-PR009

10.1158/1538-7445.brain26-pr009 Get It

Abstract Background: Alternative lengthening of telomeres (ALT) is common in isocitrate dehydrogenase (IDH) mutant astrocytomas, but how telomere length variability contributes to genome instability remains unclear. We hypothesized that chromosome arm–specific telomere heterogeneity underlies distinct patterns of somatic structural variation (SV), copy-number alteration (CNA), and extrachromosomal DNA (ecDNA) formation. Methods: Oxford Nanopore long-read whole-genome sequencing (∼20–40x coverage) was performed in a clinical cohort of n = 20 IDH-mutant astrocytomas. Somatic SVs were called with Severus and filtered to a high-confidence tumor-specific set. CNAs were inferred by read-depth segmentation (DNAcopy) and further refined using a long-read CNA framework (Wakhan). Chromosome arm–specific telomere length was estimated with Telogator, and SV breakpoints were annotated for enrichment near subtelomeric and pericentromeric regions. Associations between arm-level telomere length and SV/CNA features (rate and proportion) were tested using linear mixed-effects models with patient as a random effect. High-level amplification regions were defined directly from CNA segments with high copy number, and ecDNA-like circular amplicons were subsequently reconstructed from amplified intervals using Decoil. Results: IDH-mutant astrocytomas displayed pronounced SV heterogeneity, with complex breakends (BNDs) dominating the somatic SV landscape. SVs were spatially patterned, as deletions and insertions preferentially accumulated near subtelomeric and pericentromeric domains, implicating chromosome ends and repeat-rich regions as recurrent substrates for rearrangement. At the tumor level, markedly shortened telomeres were associated with increased SV burden and CNA burden, consistent with telomere attrition as a correlate of genome-wide structural instability in highly rearranged genomes. At higher resolution, telomere length varied substantially across chromosome arms and classified distinct structural outcomes: arms with shorter telomeres were enriched for complex insertional SVs, whereas arms with relatively elongated telomeres more frequently carried focal high-level amplifications and ecDNA-like circular amplicons. Conclusions: These findings reveal a link between arm-specific telomere heterogeneity and the emergence of structural and amplification architectures in IDH-mutant astrocytomas. Telomere remodeling may influence where rearrangements and ecDNA structures arise, offering potential biomarkers of genome instability and tumor evolution. Generative AI was used to improve language clarity; all content was verified by the authors. Citation Format: Maryam Jehangir, Kristen Drucker, T. Rhyker Ranallo-Benavidez, Thomas M. Kollmeyer, Ayse Keskus, Daniel Lachance, Jeanette E. Eckel-Passow, Ofer Shoshani, Mikhail Kolmogorov, Robert B. Jenkins, Floris P. Barthel. Telomere length heterogeneity shapes structural and amplification landscapes in IDH-mutant astrocytoma [abstract]. In: Proceedings of the AACR Special Conference in Cancer Research: Brain Cancer; 2026 Mar 23-25; Philadelphia, PA. Philadelphia (PA): AACR; Cancer Res 2026;86(6_Suppl):Abstract nr PR009.
Interrater Variability in the Application of the Goldman Criteria to Medical Autopsies
Chambers, Meagan , Bartholow, Tanner, Long, Thomas , Tenezaca, Felipe Carrasco, Phillips, Ronald L., Wanner, Shera N. , Roden, Anja C. , Castro, Eumenia , Rapkiewicz, Amy , Rojiani, Amyn M. , Sanchez, Harold, Carrasco-Tenezaca, Felipe , Phillips, Ronald, Chen, Sonja , Harper, Holly , Priemer, David S.

Mayo Clinic

Archives of Pathology & Laboratory Medicine | March 20, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.5858/arpa.2025-0487-oa | PMID 41856367 Get It

Context.— The Goldman criteria are widely used to categorize diagnostic discrepancies in autopsy reports for hospital quality assurance. Despite their adoption, little is known about how consistently they are applied across institutions. Objective.— To evaluate the interrater reliability among academic pathologists applying the Goldman criteria to classify missed diagnoses in autopsy cases. Design.— Thirty autopsy cases from 2 academic hospitals were reviewed by 5 experienced autopsy pathologists. Each reviewer independently assigned Goldman classification scores (class I–IV) to missed diagnoses based on the original 1983 definitions. Consensus was defined as at least 60% agreement (≥3 of 5 raters). Fleiss κ and Gwet AC1 were calculated to assess interrater reliability. Results.— A total of 196 missed diagnoses were identified by at least 1 rater. Only 26% (51 of 196) achieved a consensus Goldman classification, and just 4% (8 of 196) had unanimous classification agreement. Most diagnoses (65%; 127 of 196) were not identified by at least 3 raters. Among consensus classification ratings, 49% (25 of 51) were class IV. Fleiss κ was 0.176 (slight agreement) while Gwet AC1 was 0.390 (fair agreement). Collapsing major (classes I–II) and minor (classes III–IV) categories modestly improved agreement. Conclusions.— Interrater agreement in applying the Goldman criteria is only fair to moderate, suggesting significant subjectivity in their application. As the criteria are used for institutional comparison and quality metrics, efforts to standardize definitions and provide reviewer training are warranted to improve reproducibility and utility.
Modeling cis -regulatory variation in human brain enhancers across a large Parkinson’s Disease cohort
Sigalova, Olga , Pančíková, Alexandra , Man, Julie De , Theunis, Koen , Hulselmans, Gert , Konstantakos, Vasileios , Stuyven, Bram , Brabandere, Anton De, Geurts, Jarne , Mikorska, Antonina , Mukherjee, Shinjini , Vandereyken, Katy, Davie, Kristofer , Mahieu, Lukas, Adler, Charles H., Beach, Thomas G., Serrano, Geidy E., Voet, Thierry , Aerts, Stein , Sigalova, Olga M , De Man, Julie , Hulselmans, Gert J , De Brabandere, Anton , Abouelasrar Salama, Sara , Vandereyken, Katy , Davie, Kristofer , Mahieu, Lukas , Adler, C H , Beach, Thomas G , Serrano, Geidy E , Voet, Thierry , Demeulemeester, Jonas , Aerts, Stein , Adler, Charles H. , Beach, Thomas G. , Serrano, Geidy E.

Mayo Clinic

No container title available | March 19, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.64898/2026.03.15.711881 | PMID 41889906 Get It

Abstract Genome-wide association studies (GWAS) have linked more than a hundred non-coding genomic loci to Parkinson’s disease (PD) risk. Deciphering their functional impact on gene regulation requires cell type-aware modeling approaches to assess the effects of sequence variation on enhancer function and target gene expression. To address this challenge, we generated a comprehensive matched dataset from 190 human donors (115 controls and 75 PD), comprising long-read whole-genome sequencing alongside single nucleus multiome atlases (snATAC-seq and snRNA-seq for 3.1 and 1.1 million nuclei respectively) of the anterior cingulate cortex and substantia nigra. By integrating chromatin accessibility quantitative trait loci (caQTL), DNA methylation QTL (meQTL), and allele-specific chromatin accessibility (ASCA), we identified 53,841 high-confidence cis -acting genetic variants that modulate cell type-specific enhancer accessibility in one or both brain regions. We further demonstrate that sequence-to-function models can accurately predict the impact of these variants directly from the genomic sequence. Novel explainability approaches allowed stratifying these variants according to their regulatory function, with the majority disrupting specific transcription factor binding sites in a cell type specific manner. Integrating these “enhancer variants” (EV) with eQTL mapping and gene locus modeling linked a subset of EVs to their target genes. Finally, we applied these models to prioritize regulatory variants at known PD GWAS loci, bypassing statistical limitations in rare disease-relevant populations like dopaminergic neurons. All together, we establish a unique resource and new sequence modeling strategies to interpret functional non-coding variation in the human brain.